The Science Paper Behind Microsoft’s AI Doctor Comparison
AIThis post was created with the assistance of artificial intelligence (AI).

🔍 Read the full analysis: The Science Paper Behind Microsoft’s AI Doctor Comparison on ThorstenMeyerAI.com

Buying for a business?Offer from Amazon

Get business pricing on office and shipping supplies

  • Business-only prices and quantity discounts
  • Tax-exempt purchasing
  • Multiple users, one account, clear invoices
As an affiliate, we earn on qualifying purchases.

TL;DR

A Science paper published Oct. 22 reports that Microsoft’s MAI-DxO system achieved 83.2% diagnostic accuracy on 304 complex NEJM cases, compared with 36.1% for generalist physicians using reference materials. The study tested text-based historical cases in a simulator, not patient care, and Microsoft has not reported an independent replication.

Microsoft’s MAI-DxO diagnostic AI scored 83.2% on 304 complex medical cases in a study published Oct. 22 in Science, compared with 36.1% for generalist physicians using textbooks and the internet, according to the paper. The peer-reviewed results concern historical, text-based cases in a simulator, not diagnoses made for real patients, so they do not establish that the system improves clinical care.

The study, titled “Sequential diagnosis with language models,” evaluated a benchmark designed to mimic parts of diagnostic reasoning. A case begins with a short summary; the system must request further information, such as answers to questions or test results, from a model holding the case file. The benchmark scores the final diagnosis and estimates the cost of the tests requested. Microsoft calls the benchmark the Sequential Diagnosis Benchmark.

Microsoft’s reported results include a second set of 325 emergency department cases, on which MAI-DxO scored 80.3% and physicians scored 46.8%. For the 304 complex cases, the physician score was 22.3% without reference materials and 36.1% with textbooks and internet access. These are study results for the specific cases and test conditions; they are not measured rates of accuracy in everyday medical practice.

The system combines a language model with an orchestration process in which virtual agents propose diagnoses, choose follow-up questions or tests, and critique one another. Microsoft’s chart also reports that GPT-5 alone scored 78.9% on the complex cases, before the MAI-DxO system’s orchestration layer was added. That comparison suggests much of the measured performance came from the underlying model, while the added process contributed a smaller increase. The paper also estimates testing costs, but those figures rely on assigned prices rather than actual hospital spending.

At a glance
reportWhen: Published Oct. 22, 2026; a prospective…
The developmentMicrosoft’s MAI-DxO diagnostic system has been described in a peer-reviewed Science paper, which reports results from simulated tests on historical medical cases.
Thorsten Meyer AI
Science · 22 Oct 2026

Infographic 01 · The scoreboard

83% vs. 36%: the number, and who it was measured against.

Microsoft’s diagnostic system beat individual generalist physicians by a wide margin on a simulated, step-by-step test. The comparison group decides how much that says.

83.2%MAI-DxO on 304 hard NEJM cases
36.1%generalist physicians with textbooks and internet
22.3%generalist physicians without references
80.3 / 46.8emergency cases: MAI-DxO vs. physicians, in %

Hard cases (NEJM)

Diagnostic accuracy, 304 case records

  • MAI-DxOno test budget83.2%
  • GPT-5 alonesame benchmark, no orchestration78.9%
  • Physicians, open booktextbooks and internet36.1%
  • Physicians, closed bookno references22.3%

Physician averages rest on 662 (open book) and 764 (closed book) case attempts, per Microsoft’s chart data.

Who was compared

The fine print behind “beats doctors”

  • Generalists only: primary care doctors and hospital generalists. No specialists, no teams.
  • Working alone: no colleagues; in the preprint also no search engines or language models.
  • Text-only, historical cases: no real patients, no physical exam, no imaging.
  • Hard by design: rare teaching cases; no healthy patients, so false alarms were not measured.
  • Self-reported: all 15 authors are listed with Microsoft affiliations; peer-reviewed, not independently replicated.

Sources: Science 394, 423–428 (22 Oct 2026); Microsoft AI, “Building Medical Superintelligence” (22 Oct 2026) and its charts; physician cohort details from the arXiv 2506.22405 preprint (2025).
Powered by Thorsten Meyer AI

What the Scores Say About Diagnosis

The study matters because it tests more than whether an AI can select a diagnosis when all the facts are already provided. In the benchmark, the system has to decide what information to seek and when to stop, choices that form part of real diagnostic work. The authors also track estimated test costs, an effort to examine efficiency alongside accuracy.

But the comparison does not show that MAI-DxO is ready to replace doctors or improve patient outcomes. The cases were historical and selected for complexity, and participants interacted with a text-based simulator rather than patients. The physician group consisted of generalists working individually, while the AI system used multiple agents. As TechCrunch noted in its account of the paper, difficult cases may be referred to specialists or handled by teams in practice; those groups were not part of the reported comparison.

The findings could inform later studies and product development, but decisions by hospitals, insurers and patients require evidence about performance in clinical settings. That includes whether the system can handle ordinary cases, avoid unnecessary tests, recognize uncertainty and work safely with clinicians. The present scores do not answer those questions.

Amazon

medical diagnostic AI software

As an affiliate, we earn on qualifying purchases.

As an affiliate, we earn on qualifying purchases.

How the Benchmark Was Built

The Science article follows an earlier, non-peer-reviewed version posted on arXiv in June 2025. That preprint reported a different model and a larger gap between AI and doctors. The later paper appeared in Science, volume 394, pages 423–428, on Oct. 22, 2026. Its 15 listed authors are affiliated with Microsoft, including Microsoft AI chief executive Mustafa Suleyman.

The source material’s account of the full paper’s methods draws on the preprint, which it says may differ from the final version. In that earlier account, a model judged answers against the published diagnosis, while physicians re-graded a sample and showed good, but imperfect, agreement with the automated scoring. If a requested test result was absent from the case file, a gatekeeper model generated a synthetic result. Estimated test prices came from a 2023 U.S. hospital price list mapped to billing codes, plus a fixed $300 physician visit charge; the authors described those prices as approximations.

The physician comparison also has limits. The preprint described 21 U.S. and UK generalists—17 in primary care and four hospital generalists—with a median of 12 years’ experience. They worked alone and were not allowed to use search engines or language models in the closed-book condition. According to the source account, the doctors were scored on 56 held-out cases, while the AI was evaluated on all 304. The published Science figures include an additional open-book physician result.

“I really believe that in 2027, we will be on the verge of a coding style breakthrough for medical records.”

— Microsoft AI chief executive Mustafa Suleyman, speaking to TechCrunch

Limits the Trial Leaves Open

The published scores do not show how MAI-DxO would perform with live patients, physical examinations or imaging. The source material says the benchmark’s NEJM cases had no healthy patients or harmless explanations, limiting what the test could reveal about false alarms. It is also unclear from the supplied reporting how the final Science paper handled every methodological detail that appeared in the earlier preprint.

Microsoft’s results have been peer-reviewed, but the source material reports no independent replication. Peer review evaluates the paper’s methods and reporting; it does not mean outside researchers have reproduced its findings. The study also does not establish whether the system’s accuracy, test ordering or costs would hold across routine cases, different hospitals or patient populations.

A Planned Study With Patients

The next development identified in the source material is a prospective study at Beth Israel Deaconess Medical Center in Boston. Consenting patients are expected to interact with the system alongside their usual care. That setting could provide evidence closer to clinical use than a retrospective case benchmark, although the supplied material does not give a start date, sample size, study design or publication timeline.

Until those details and results are available, the Science paper should be read as evidence about performance on defined simulations—not proof of benefit in hospitals. Key questions for further testing include how the system performs against specialist teams, whether it changes care decisions, how often it prompts unnecessary testing, and whether its estimates of diagnostic accuracy and cost hold in real-world practice.

Key Questions

What did Microsoft’s MAI-DxO study report?

The paper reported 83.2% diagnostic accuracy for MAI-DxO on 304 complex cases, versus 36.1% for generalist physicians with reference materials. Those figures apply to the study’s simulated cases and conditions.

Was MAI-DxO tested on real patients?

No. The reported benchmark used historical, text-based medical cases in a simulator. The source material says a prospective study involving consenting patients is planned at Beth Israel Deaconess Medical Center.

Were the doctors in the comparison specialists?

The physician group described in the source material consisted of primary care doctors and hospital generalists working alone. Specialists and clinical teams were not included in the comparison described there.

Does peer review mean the results were independently confirmed?

No. Publication in Science means the paper underwent peer review, but the supplied reporting does not identify an independent replication of Microsoft’s findings.

Source: ThorstenMeyerAI.com

This content is for general information only and is not financial, tax or legal advice. Consult a qualified professional for decisions about your money.
FALL

Fall Picks

As an affiliate, we earn on qualifying purchases.

You May Also Like

Nvidia, CoreWeave, And Nebius: Inside The Circular Financing Of The GPU Boom

Exploring how Nvidia, CoreWeave, and Nebius are financing the GPU boom through circular investment strategies amid rising demand.

Brunswick Corporation Releases Investor Day Materials Highlighting Long-Term Growth Strategy

Brunswick Corporation releases investor day materials emphasizing its long-term growth plans, signaling confidence in future expansion and innovation.

New Delhi Marks UN Day For South-South Cooperation With Push To Scale Dryland Innovation Across The Global South

India’s New Delhi commemorates UN Day for South-South Cooperation by launching initiatives to expand dryland farming innovations across the Global South.

Graded Card Displays Can Look Cheap Without Layout Planning

Keen attention to layout transforms graded card displays from cheap to impressive; discover how proper planning elevates your showcase.